SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
193 hedge funds and large institutions have $581M invested in Sage Therapeutics in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 76 increasing their positions, 54 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 40
47% less capital invested
Capital invested by funds: $1.1B → $581M (-$516M)
Holders
193
Holding in Top 10
–
Calls
$10.1M
Puts
$2.18M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$8.59M | |
| 3 | +$8.52M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$7.38M |
| 5 |
Renaissance Technologies
New York
|
+$6.64M |
Top Sellers
| 1 | -$60.4M | |
| 2 | -$25.9M | |
| 3 | -$12.9M | |
| 4 |
SC
Samlyn Capital
New York
|
-$11.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.14M |